Neurosurgery AI Lab & Department of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Department of Neurosurgery, Kantonsspital St.Gallen, St.Gallen, Switzerland.
World Neurosurg. 2022 Oct;166:e294-e305. doi: 10.1016/j.wneu.2022.07.002. Epub 2022 Jul 7.
Candidates for anterior cervical discectomy and fusion (ACDF) have a higher rate of opioid use than does the public, but studies on preoperative opioid use have not been conducted. We aimed to understand how preoperative opioid use affects post-ACDF outcomes.
The MarketScan Database was queried from 2007 to 2015 to identify adult patients who underwent an ACDF. Patients were classified into separate cohorts based on the number of separate opioid prescriptions in the year before their ACDF. Ninety-day postoperative complications, postoperative readmission, reoperation, and total inpatient costs were compared between opioid strata. Propensity score-matched patient cohorts were calculated to balance comorbidities across groups.
Of 81,671 ACDF patients, 31,312 (38.3%) were nonusers, 30,302 (37.1%) were mild users, and 20,057 (24.6%) were chronic users. Chronic opioid users had a higher comorbidity burden, on average, than patients with less frequent opioid use (P < 0.001). Chronic opioid users had higher rates of postoperative complications (9.1%) than mild opioid users (6.0%) and nonusers (5.3%) (P < 0.001) and higher rates of readmission and reoperation. After balancing opioid nonusers versus chronic opioid users along with demographic characteristics, preoperative comorbidity, and operative characteristics, postoperative complications remained elevated for chronic opioid users relative to opioid nonusers (8.6% vs. 5.7%; P < 0.001), as did rates of readmission and reoperation.
Chronic opioid users had more comorbidities than opioid nonusers and mild opioid users, longer hospitalizations, and higher rates of postoperative complication, readmission, and reoperation. After balancing patients across covariates, the outcome differences persisted, suggesting a durable association between preoperative opioid use and negative postoperative outcomes.
接受前路颈椎间盘切除术和融合术(ACDF)的患者比普通人群使用阿片类药物的比例更高,但目前尚未对术前使用阿片类药物进行研究。本研究旨在了解术前使用阿片类药物如何影响 ACDF 术后结果。
从 2007 年至 2015 年,我们对 MarketScan 数据库进行了查询,以确定接受 ACDF 的成年患者。根据 ACDF 前一年单独开具的阿片类药物处方数量,患者被分为单独的队列。比较了不同阿片类药物分层患者的 90 天术后并发症、术后再入院、再次手术和总住院费用。计算了倾向评分匹配的患者队列,以平衡组间的合并症。
在 81671 例 ACDF 患者中,31312 例(38.3%)为非使用者,30302 例(37.1%)为轻度使用者,20057 例(24.6%)为慢性使用者。慢性阿片类药物使用者的合并症负担平均高于使用频率较低的阿片类药物的患者(P <0.001)。与轻度阿片类药物使用者(6.0%)和非使用者(5.3%)相比,慢性阿片类药物使用者的术后并发症发生率(9.1%)更高(P <0.001),且再入院和再次手术的发生率也更高。在平衡了阿片类药物非使用者与慢性阿片类药物使用者,以及人口统计学特征、术前合并症和手术特征后,与阿片类药物非使用者相比,慢性阿片类药物使用者的术后并发症仍较高(8.6% vs. 5.7%;P <0.001),再入院和再次手术的发生率也较高。
慢性阿片类药物使用者比阿片类药物非使用者和轻度阿片类药物使用者的合并症更多,住院时间更长,术后并发症、再入院和再次手术的发生率更高。在对协变量进行平衡后,结果差异仍然存在,这表明术前使用阿片类药物与术后不良结局之间存在持久的关联。